Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgA-induced eosinophil degranulation.

R I Abu-Ghazaleh1, T Fujisawa, J Mestecky

  • 1Department of Immunology, Mayo Medical School, Rochester, MN 55905.

Journal of Immunology (Baltimore, Md. : 1950)
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memory and Celebration: Dr. James J. Lee.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

Clinical and experimental immunology·2014
Same author

Eosinophil major basic protein activates human cord blood mast cells primed with fibroblast membranes by integrin-β1.

Allergy·2013
Same author

The consequences of not having eosinophils.

Allergy·2013
Same author

Eosinophil peroxidase induces the expression and function of acid-sensing ion channel-3 in allergic rhinitis: in vitro evidence in cultured epithelial cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
Same author

The role of eosinophil major basic protein in angiogenesis.

Allergy·2009

Secretory IgA (sIgA) is a potent activator of eosinophil degranulation, triggering the release of eosinophil-derived neurotoxin (EDN). This suggests sIgA plays a key role in immune responses at mucosal surfaces.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Eosinophils are crucial effector cells in allergic and parasitic conditions.
  • Understanding eosinophil effector mechanisms is vital for treating related diseases.

Purpose of the Study:

  • To investigate the role of different immunoglobulin (Ig) isotypes in mediating eosinophil effector functions.
  • To identify the primary Ig isotype responsible for eosinophil degranulation.

Main Methods:

  • Human normodense eosinophils were incubated with Sepharose beads coated with various Ig isotypes (IgG, IgA, sIgA) or control substances.
  • Eosinophil degranulation was assessed by measuring the release of eosinophil-derived neurotoxin (EDN).
  • Eosinophil binding to coated beads was quantified.

Main Results:

Related Experiment Videos

  • Eosinophils released EDN when exposed to IgG and IgA isotypes.
  • Secretory IgA (sIgA) induced significantly more potent eosinophil degranulation than IgG.
  • Higher percentages of eosinophils bound to sIgA-coated beads compared to IgG- or IgA-coated beads.

Conclusions:

  • Secretory IgA (sIgA) is a primary mediator of eosinophil effector functions.
  • sIgA may be particularly important at mucosal surfaces in conditions like helminth infections, hypersensitivity diseases, and asthma.
  • These findings highlight sIgA's role in immune responses and suggest therapeutic targets.